We are live on ! Find out more
LOAMS

Lombard Odier Asset Management (Switzerland) Portfolio holdings

AUM $2.63B
1-Year Est. Return 31.52%
This Fund
S&P 500
This Quarter Est. Return
-13.16%
1 Year Est. Return
+31.52%
3 Year Est. Return
+98.77%
5 Year Est. Return
+107.98%
10 Year Est. Return
+494.97%
AUM
$1.18B
AUM Growth
-$93.5M
Cap. Flow
+$113M
Cap. Flow %
9.6%
Top 10 Hldgs %
21.21%
Holding
341
New
184
Increased
50
Reduced
82
Closed
18

Top Buys

Rank Stock Value
1
DXCM icon
DexCom
DXCM
+$12.6M
2
MFC icon
Manulife Financial
MFC
+$7.56M
3
GKOS icon
Glaukos
GKOS
+$7.01M
4
AMZN icon
Amazon
AMZN
+$6.67M
5
GOOGL icon
Alphabet (Google) Class A
GOOGL
+$6.26M

Top Sells

Rank Stock Value
1
ABBV icon
AbbVie
ABBV
+$11.7M
2
UNH icon
UnitedHealth
UNH
+$11.3M
3
IRTC icon
iRhythm Holdings
IRTC
+$9.63M
4
HALO icon
Halozyme
HALO
+$8.33M
5
CRSP icon
CRISPR Therapeutics
CRSP
+$7.47M

Sector Composition

Rank Sector Weight
1 Healthcare 46.65%
2 Financials 13.97%
3 Consumer Discretionary 13.94%
4 Technology 8.36%
5 Industrials 5.54%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
AES icon
101
AES
AES
$10.5B
$2.55M 0.22%
121,417
+45,788
+61% +$999K
TREX icon
102
Trex
TREX
$5.05B
$2.5M 0.21%
+46,008
New +$2.78M
VRSK icon
103
Verisk Analytics
VRSK
$23.5B
$2.49M 0.21%
+14,402
New +$2.69M
DAR icon
104
Darling Ingredients
DAR
$10B
$2.48M 0.21%
41,455
+27,168
+190% +$2.06M
MU icon
105
Micron Technology
MU
$1.03T
$2.42M 0.2%
43,722
+17,853
+69% +$1.21M
CRM icon
106
Salesforce
CRM
$158B
$2.41M 0.2%
14,609
-1,576
-10% -$278K
DKS icon
107
Dick's Sporting Goods
DKS
$18.1B
$2.4M 0.2%
+31,772
New +$2.82M
META icon
108
Meta Platforms (Facebook)
META
$1.47T
$2.39M 0.2%
14,816
-3,270
-18% -$631K
KPTI icon
109
Karyopharm Therapeutics
KPTI
$46M
$2.32M 0.2%
34,253
-17,484
-34% -$1.6M
QTRX icon
110
Quanterix
QTRX
$139M
$2.27M 0.19%
140,312
-78,235
-36% -$1.61M
SBNY
111
DELISTED
Signature Bank
SBNY
$2.18M 0.18%
+12,150
New +$2.72M
BXP icon
112
Boston Properties
BXP
$10.8B
$2.14M 0.18%
24,044
+7,681
+47% +$850K
CMI icon
113
Cummins
CMI
$87.8B
$2.06M 0.17%
10,637
+484
+5% +$96.8K
MELI icon
114
Mercado Libre
MELI
$92.7B
$1.99M 0.17%
+3,122
New +$2.72M
XOM icon
115
ExxonMobil
XOM
$657B
$1.92M 0.16%
22,450
+4,506
+25% +$406K
LULU icon
116
lululemon athletica
LULU
$13.7B
$1.91M 0.16%
+6,996
New +$2.24M
JPM icon
117
JPMorgan Chase
JPM
$971B
$1.91M 0.16%
16,923
-6,119
-27% -$758K
HXL icon
118
Hexcel
HXL
$7.74B
$1.81M 0.15%
+34,615
New +$1.9M
HD icon
119
Home Depot
HD
$342B
$1.79M 0.15%
+6,535
New +$1.93M
PFE icon
120
Pfizer
PFE
$150B
$1.78M 0.15%
34,007
-3,783
-10% -$193K
MRK icon
121
Merck
MRK
$328B
$1.78M 0.15%
19,524
-617
-3% -$54.7K
AMED
122
DELISTED
Amedisys
AMED
$1.74M 0.15%
16,538
-48,462
-75% -$6.19M
MA icon
123
Mastercard
MA
$490B
$1.59M 0.13%
+5,042
New +$1.74M
BRK.B icon
124
Berkshire Hathaway Class B
BRK.B
$1.09T
$1.58M 0.13%
+5,783
New +$1.81M
HLT icon
125
Hilton Worldwide
HLT
$72.6B
$1.56M 0.13%
13,990
+1,476
+12% +$204K

Similar funds

Lombard Odier Asset Management (Switzerland)'s Q2 2022 Portfolio in Review

As of Q2 2022, Lombard Odier Asset Management (Switzerland) held 341 positions worth $1.18B, down 7.3% from $1.27B the previous quarter. Its ten largest holdings account for 21% of the portfolio.

Lombard Odier Asset Management (Switzerland) deployed $113M of net new capital in Q2 2022, opening 184 new positions and adding to 50 existing holdings. Its largest new stake was Glaukos: 147,742 shares worth $6.71M.

By sector, the portfolio is most concentrated in Healthcare at 47% of assets, down from 57% a quarter earlier, followed by Financials and Consumer Discretionary.

On the sell side, the largest reduction was AbbVie, an estimated $11.7M trimmed.

  • Lombard Odier Asset Management (Switzerland)'s largest Q2 2022 buy was Glaukos: 147,742 shares worth $6.71M.
  • Lombard Odier Asset Management (Switzerland) added most to DexCom in Q2 2022, an estimated $12.6M increase.
  • Lombard Odier Asset Management (Switzerland)'s biggest Q2 2022 reduction was AbbVie, cutting an estimated $11.7M.
  • Lombard Odier Asset Management (Switzerland) fully exited G1 Therapeutics, Inc. Common Stock in Q2 2022, selling an estimated $4.12M.
  • Lombard Odier Asset Management (Switzerland)'s ten largest holdings make up 21% of its $1.18B portfolio in Q2 2022.
  • Lombard Odier Asset Management (Switzerland) opened 184 new positions and closed 18 in Q2 2022.
  • Lombard Odier Asset Management (Switzerland)'s portfolio value fell 7.3% quarter-over-quarter to $1.18B.

Based on Lombard Odier Asset Management (Switzerland)'s 13F filing for Q2 2022, filed 15 Aug 2022.